Clinical-stage biopharma company developing inhalation drug delivery therapies and next-generation, direct-to-lung therapeutics AUSTIN, Texas --(BUSINESS WIRE)--Nov. 19, 2019-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and

The clinical-stage biopharma company celebrates its successful $22 million IPO AUSTIN, Texas --(BUSINESS WIRE)--Nov. 18, 2019-- TFF Pharmaceuticals, Inc . (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its

AUSTIN, Texas--( BUSINESS WIRE )--TFF Pharmaceuticals, Inc. (Nasdaq: TFFP), an early-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform, today announced the pricing of its initial